Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier F Torres-Roca

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous MelanomaTobin Strom, Javier F Torres-Roca, Akash Parekh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine ConferenceWilliam A Hall, Carmen Bergom, Reid F Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2024
Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic AssociationsWilliam A Hall, Angela J Mathison, Elias DeVoe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancerChi Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li, et al.
Annals of Surgical Oncology|June 3, 2016
Radiation Therapy is Associated with Improved Outcomes in Merkel Cell CarcinomaTobin Strom, Michael Carr, Jonathan S Zager, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2020
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLCJacob G Scott, Geoff Sedor, Jessica A Scarborough, et al.
The Lancet. Oncology|December 21, 2016
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based studyJacob G Scott, Anders Berglund, Michael J Schell, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous MelanomaTobin Strom, Javier F Torres-Roca, Akash Parekh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine ConferenceWilliam A Hall, Carmen Bergom, Reid F Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2024
Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic AssociationsWilliam A Hall, Angela J Mathison, Elias DeVoe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancerChi Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li, et al.
Annals of Surgical Oncology|June 3, 2016
Radiation Therapy is Associated with Improved Outcomes in Merkel Cell CarcinomaTobin Strom, Michael Carr, Jonathan S Zager, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2020
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLCJacob G Scott, Geoff Sedor, Jessica A Scarborough, et al.
The Lancet. Oncology|December 21, 2016
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based studyJacob G Scott, Anders Berglund, Michael J Schell, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Pageof 7